Nanotechnology in cancer treatment

Maria Mironidou-Tzouveleki M.D.; Konstantinos Imprialos; Athanasios Kintsakis

doi:10.1117/12.898643

12 September 2011 Nanotechnology in cancer treatment

Maria Mironidou-Tzouveleki M.D., Konstantinos Imprialos, Athanasios Kintsakis

Proceedings Volume 8099, Biosensing and Nanomedicine IV; 809917 (2011) https://doi.org/10.1117/12.898643
Event: SPIE NanoScience + Engineering, 2011, San Diego, California, United States

Abstract

The purpose of this paper is to analyze the current evolutions on nanotechnology and its applications on cancer theragnostics.Rapid advances and emerging technologies in nanotechnology are having a profound impact on cancer treatment. Applications of nanotechnology, which include liposomes, nanoparticles, polymeric micelles, dendrimers, nanocantilever, carbon nanotubes and quantum dots have significantly revolutionized cancer theragnostics. From a pharmaceutical viewpoint, it is critical that the biodistribution of active agents has to be controlled as much as possible. This aspect is vital in order to assure the proper efficiency and safety of the anticancer agents. These biocompatible nanocomposites provide specific biochemical interactions with receptors expressed on the surface of cancer cells. With passive or active targeting strategies, an increased intracellular concentration of drugs can be achieved in cancer cells , while normal cells are being protected from the drug simultaneously. Thus, nanotechnology restricts the extent of the adverse effects of the anticancer therapy. Treatment for metastatic breast cancer, sarcoma in AIDS patients, ovarian and lung cancer is already on market or under final phases of many clinical trials, showing remarkable results. As nanotechnology is perfected, side effects due to normal cell damage will decrease, leading to better results and lengthening patient's survival.

Citation Download Citation

Maria Mironidou-Tzouveleki M.D., Konstantinos Imprialos, and Athanasios Kintsakis "Nanotechnology in cancer treatment", Proc. SPIE 8099, Biosensing and Nanomedicine IV, 809917 (12 September 2011); https://doi.org/10.1117/12.898643

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available